Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Clinical trial NCT00307125 · COMPLETED

Trial details

NCT number: NCT00307125
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Transplant Kidney Transplant Recipient Graft Function/Survival de Novo HLA Antibodies Development

Start date: 2006-03-01
Primary completion: 2012-12-01
Enrollment: 757

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.